Ron Ellis
Directeur/Membre du Conseil chez GeneQuine Biotherapeutics GmbH
Postes actifs de Ron Ellis
Sociétés | Poste | Début | Fin |
---|---|---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Directeur/Membre du Conseil | - | - |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services CarthroniX, Inc. is a private company that is focused on developing small molecules to stimulate the growth and regeneration of articular cartilage in joints. The company is based in Lancaster, CA. The company's patented small molecule CX-1 activates a regenerative pathway that results in cartilage proliferation, cellular migration, and deposition of cartilaginous matrix. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Ron Ellis
Anciens postes connus de Ron Ellis
Sociétés | Poste | Début | Fin |
---|---|---|---|
PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | - | - |
Formation de Ron Ellis
Philadelphia College of Osteopathic Medicine | Doctorate Degree |
St. Joseph's University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Allemagne | 2 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PACIRA BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Health Technology |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services CarthroniX, Inc. is a private company that is focused on developing small molecules to stimulate the growth and regeneration of articular cartilage in joints. The company is based in Lancaster, CA. The company's patented small molecule CX-1 activates a regenerative pathway that results in cartilage proliferation, cellular migration, and deposition of cartilaginous matrix. | Health Services |